Align Technology Inc (ALGN)
Official siteHEALTHCARE • MEDICAL INSTRUMENTS & SUPPLIES • NASDAQ
Market Cap: $11.86B
Last updated: Nov 17, 2026 at 11:04 AM ET
Align Technology Inc (ALGN) Financials: Revenue, Profit and Cash Flow
Align Technology reported revenue of $4.03B for the fiscal year ended Dec 31, 2025, up 0.9% from the year before. That year, net income was $410.35M with a net margin of 10.2%, operating cash flow was $593.22M and free cash flow was $490.78M. The quarter ended Sep 30, 2026 had revenue of $1.01B and net income of $135.04M.
Revenue and Margins
The operating margin was 13.5% in the fiscal year ended Dec 2025, the lowest of the 10 years shown. Over the 9 years to Dec 2025, revenue grew from $1.08B, a compound annual rate of 15.8%.
| Fiscal year | Revenue | Growth | Gross margin | Operating margin | Net margin |
|---|---|---|---|---|---|
| Dec 2025 | $4.03B | +0.9% | 67.2% | 13.5% | 10.2% |
| Dec 2024 | $4.00B | +3.5% | 70.0% | 15.2% | 10.5% |
| Dec 2023 | $3.86B | +3.4% | 70.1% | 16.7% | 11.5% |
| Dec 2022 | $3.73B | -5.5% | 70.5% | 17.2% | 9.7% |
| Dec 2021 | $3.95B | +59.9% | 74.3% | 24.7% | 19.5% |
| Dec 2020 | $2.47B | +2.7% | 71.3% | 15.7% | 71.8% |
| Dec 2019 | $2.41B | +22.4% | 72.5% | 22.5% | 18.4% |
| Dec 2018 | $1.97B | +33.5% | 73.6% | 23.7% | 20.4% |
| Dec 2017 | $1.47B | +36.4% | 75.8% | 24.0% | 15.7% |
| Dec 2016 | $1.08B | N/A | 75.5% | 23.1% | 17.6% |
Income Statement
In the fiscal year ended Dec 2025, net income fell 2.6% from the year before. In the quarter ended Sep 2026, net income rose 138.0% from the same quarter a year earlier.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $4.03B | $4.00B | $3.86B | $3.73B | $3.95B | $2.47B | $2.41B | $1.97B | $1.47B | $1.08B |
| Cost of revenue | $1.32B | $1.20B | $1.16B | $1.10B | $1.02B | $708.71M | $662.90M | $518.63M | $356.47M | $264.58M |
| Gross profit | $2.71B | $2.80B | $2.71B | $2.63B | $2.94B | $1.76B | $1.74B | $1.45B | $1.12B | $815.29M |
| Research and development | $369.91M | $364.20M | $346.83M | $305.26M | $250.31M | $175.31M | $157.36M | $128.90M | $97.56M | $75.72M |
| Operating income | $545.75M | $607.63M | $643.34M | $642.60M | $976.40M | $387.17M | $542.49M | $466.56M | $353.61M | $248.92M |
| Net income | $410.35M | $421.36M | $445.05M | $361.57M | $772.02M | $1.78B | $442.78M | $400.24M | $231.42M | $189.68M |
| EBITDA | $806.68M | $772.21M | $766.35M | $719.48M | $1.12B | $491.83M | $629.16M | $512.80M | $395.59M | $262.36M |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.01B | $1.06B | $1.04B | $1.05B | $995.69M | $1.01B | $979.26M | $995.22M | $977.87M | $1.03B | $997.43M | $956.73M |
| Gross profit | $697.47M | $757.43M | $736.59M | $683.59M | $639.20M | $708.12M | $680.11M | $696.94M | $681.77M | $722.63M | $697.82M | $669.52M |
| Operating income | $169.16M | $154.01M | $141.96M | $155.32M | $96.30M | $163.03M | $131.10M | $144.15M | $162.30M | $147.05M | $154.13M | $171.54M |
| Net income | $135.04M | $108.29M | $112.77M | $135.76M | $56.75M | $124.61M | $93.23M | $103.81M | $115.96M | $96.56M | $105.03M | $124.01M |
Balance Sheet
As of Dec 2025, cash and equivalents exceeded short-term debt of $31.94M by $1.06B.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $6.23B | $6.21B | $6.08B | $5.95B | $5.94B | $4.83B | $2.50B | $2.05B | $1.78B | $1.40B |
| Current assets | $2.62B | $2.49B | $2.45B | $2.42B | $2.49B | $1.85B | $1.63B | $1.30B | $1.16B | $952.98M |
| Cash and equivalents | $1.09B | $1.04B | $937.44M | $942.05M | $1.10B | $960.84M | $550.42M | $636.90M | $449.51M | $389.27M |
| Total liabilities | $2.18B | $2.36B | $2.45B | $2.35B | $2.32B | $1.60B | $1.15B | $799.57M | $629.72M | $400.76M |
| Short-term debt | $31.94M | $31.06M | $29.65M | $26.57M | $22.72M | $21.73M | $15.74M | $12.03M | $17.91M | $9.24M |
| Shareholder equity | $4.05B | $3.85B | $3.63B | $3.60B | $3.62B | $3.23B | $1.35B | $1.25B | $1.15B | $995.39M |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $6.52B | $6.42B | $6.31B | $6.23B | $6.23B | $6.22B | $6.10B | $6.21B | $6.37B | $6.16B | $6.16B | $6.08B |
| Total liabilities | $2.22B | $2.19B | $2.16B | $2.18B | $2.28B | $2.31B | $2.31B | $2.36B | $2.42B | $2.40B | $2.40B | $2.45B |
| Cash and equivalents | $1.14B | $1.10B | $1.06B | $1.08B | $1.00B | $901.16M | $873.01M | $1.04B | $1.04B | $761.43M | $865.80M | $937.44M |
| Shareholder equity | $4.31B | $4.23B | $4.15B | $4.05B | $3.96B | $3.91B | $3.79B | $3.85B | $3.94B | $3.76B | $3.76B | $3.63B |
Cash Flow
In the fiscal year ended Dec 2025, free cash flow was 82.7% of operating cash flow. Share repurchases came to 94.9% of it.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $593.22M | $738.23M | $785.78M | $568.73M | $1.17B | $662.17M | $747.27M | $554.68M | $438.54M | $247.65M |
| Capital expenditures | $102.44M | $115.58M | $177.72M | $291.90M | $401.10M | $154.92M | $149.71M | $223.31M | $195.69M | $70.58M |
| Free cash flow | $490.78M | $622.65M | $608.06M | $276.83M | $771.45M | $507.26M | $597.56M | $331.37M | $242.84M | $177.08M |
| Share repurchases | $465.94M | $352.88M | $602.36M | $475.04M | $375.04M | $0 | $400.00M | $300.00M | $103.79M | $96.22M |
| Investing cash flow | -$112.44M | -$254.91M | -$195.94M | -$213.32M | -$563.43M | -$231.51M | -$350.44M | $6.93M | -$251.48M | $73.03M |
| Financing cash flow | -$464.58M | -$355.72M | -$598.34M | -$501.69M | -$458.33M | -$30.81M | -$485.54M | -$369.43M | -$135.50M | -$95.52M |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $182.92M | $192.76M | $151.04M | $223.18M | $188.72M | $128.65M | $52.68M | $286.08M | $263.66M | $159.83M | $28.66M | $46.90M |
| Capital expenditures | $45.03M | $35.66M | $30.79M | $35.92M | $19.76M | $21.48M | $25.29M | $22.96M | $29.80M | $53.45M | $9.37M | $33.41M |
| Free cash flow | $137.89M | $157.09M | $120.26M | $187.26M | $168.96M | $107.17M | $27.39M | $263.12M | $233.86M | $106.38M | $19.30M | $13.48M |
Frequently Asked Questions About ALGN
What is Align Technology's annual revenue?
Align Technology reported revenue of $4.03B for the fiscal year ended Dec 31, 2025.
How fast is Align Technology's revenue growing?
Revenue was up 0.9% for the fiscal year ended Dec 31, 2025 compared with the year before. The compound annual revenue growth rate over 3 years was 2.6%.
Is Align Technology profitable?
Yes. Align Technology reported net income of $410.35M for the fiscal year ended Dec 31, 2025, with a net margin of 10.2%.
How much free cash flow does ALGN generate?
For the fiscal year ended Dec 31, 2025, operating cash flow of $593.22M minus capital expenditures of $102.44M produced free cash flow of $490.78M.
How much debt does Align Technology have?
The balance sheet dated Dec 31, 2025 reported short-term debt of $31.94M and cash and equivalents of $1.09B.
ALGN pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors